ABIVAX Société Anonyme

BST:2X10 Stock Report

Market Cap: €517.0m

ABIVAX Société Anonyme Future Growth

Future criteria checks 2/6

ABIVAX Société Anonyme is forecast to grow earnings and revenue by 1.9% and 65.1% per annum respectively. EPS is expected to decline by 4% per annum. Return on equity is forecast to be -236.6% in 3 years.

Key information

1.9%

Earnings growth rate

-4.0%

EPS growth rate

Biotechs earnings growth34.8%
Revenue growth rate65.1%
Future return on equity-236.6%
Analyst coverage

Good

Last updated04 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BST:2X10 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267-216-201-2097
12/31/20256-186-166-1608
12/31/20247-163-123-1238
6/30/20249-177-155-155N/A
3/31/20247-163-126-126N/A
12/31/20234-148-97-97N/A
9/30/20234-120-77-77N/A
6/30/20234-92-57-57N/A
3/31/20234-76-56-55N/A
12/31/20224-61-54-54N/A
9/30/20228-54N/AN/AN/A
6/30/20222-47-46-46N/A
3/31/20221-45-46-46N/A
12/31/20214-42-45-45N/A
9/30/20210-41N/AN/AN/A
6/30/20210-39-46-45N/A
3/31/20210-38-38-38N/A
12/31/20200-38-31-30N/A
9/30/20200-35N/AN/AN/A
6/30/20200-32-25-24N/A
3/31/20200-31-27-26N/A
12/31/20190-31-28-27N/A
9/30/20190-27-23-22N/A
6/30/20190-23-18-17N/A
3/31/20191-19-17-16N/A
12/31/20181-16-15-15N/A
9/30/20181-14-14-13N/A
6/30/20181-13-12-11N/A
3/31/20181-12N/A-10N/A
12/31/20170-11N/A-8N/A
9/30/20170-11N/AN/AN/A
6/30/20170-12N/A-11N/A
3/31/20170-13N/A-14N/A
12/31/20160-14N/A-16N/A
9/30/20160-16N/AN/AN/A
6/30/20160-17N/A-24N/A
3/31/20160-17N/A-19N/A
12/31/20150-16N/A-15N/A
9/30/20150-14N/AN/AN/A
6/30/20150-12N/AN/AN/A
3/31/20150-8N/AN/AN/A
12/31/20140-5N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2X10 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 2X10 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 2X10 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 2X10's revenue (65.1% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: 2X10's revenue (65.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 2X10 is forecast to be unprofitable in 3 years.


Discover growth companies